These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
820 related articles for article (PubMed ID: 27490003)
1. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Kayssi A; Al-Atassi T; Oreopoulos G; Roche-Nagle G; Tan KT; Rajan DK Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011319. PubMed ID: 27490003 [TBL] [Abstract][Full Text] [Related]
2. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries. Kayssi A; Al-Jundi W; Papia G; Kucey DS; Forbes T; Rajan DK; Neville R; Dueck AD Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012510. PubMed ID: 30684445 [TBL] [Abstract][Full Text] [Related]
3. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia. Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919 [TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials. Fusaro M; Cassese S; Ndrepepa G; Tepe G; King L; Ott I; Nerad M; Schunkert H; Kastrati A JACC Cardiovasc Interv; 2013 Dec; 6(12):1284-93. PubMed ID: 24355118 [TBL] [Abstract][Full Text] [Related]
5. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease. Jongsma H; Bekken JA; de Vries JP; Verhagen HJ; Fioole B J Vasc Surg; 2016 Nov; 64(5):1503-1514. PubMed ID: 27478005 [TBL] [Abstract][Full Text] [Related]
6. Intravascular brachytherapy for peripheral vascular disease. Andras A; Hansrani M; Stewart M; Stansby G Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003504. PubMed ID: 24399686 [TBL] [Abstract][Full Text] [Related]
7. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395 [TBL] [Abstract][Full Text] [Related]
8. Angioplasty versus bare metal stenting for superficial femoral artery lesions. Chowdhury MM; McLain AD; Twine CP Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006767. PubMed ID: 24959692 [TBL] [Abstract][Full Text] [Related]
9. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203 [TBL] [Abstract][Full Text] [Related]
10. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769 [TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial. Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828 [TBL] [Abstract][Full Text] [Related]
16. Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions. Zeller T; Brechtel K; Meyer DR; Noory E; Beschorner U; Albrecht T J Endovasc Ther; 2020 Oct; 27(5):683-690. PubMed ID: 32666871 [No Abstract] [Full Text] [Related]
17. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons. Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400 [TBL] [Abstract][Full Text] [Related]
18. The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial. Teichgräber U; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Thieme M; Blessing E; Treitl M; Lichtenberg M; von Flotow P; Vogel B; Werk M; Riambau V; Wienke A; Lehmann T; Sixt S Trials; 2016 Oct; 17(1):528. PubMed ID: 27793175 [TBL] [Abstract][Full Text] [Related]
19. Subintimal angioplasty for lower limb arterial chronic total occlusions. Chang Z; Zheng J; Liu Z Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009418. PubMed ID: 27858952 [TBL] [Abstract][Full Text] [Related]
20. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M; Trials; 2014 Feb; 15():63. PubMed ID: 24552184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]